http://www.publicwire.com WORCESTER, Mass. and TORONTO, March 5, 2014 /PRNewswire via COMTEX/ Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com) has received Notices of Allowance from the United States Patent Office relating to applications for the use of therapeutic vaccines targeting human papilloma virus (HPV) caused cancers as [...]
http://www.publicwire.com/2014/03/05/gnbt-generex-subsidiary-antigen-express-receives-patents-for-vaccines-targeting-hpv-induced-cancers-and-influenza/
No comments:
Post a Comment